Otolaryngology, Head and Neck Surgery Unit, Ziv Medical Center, Zefat, Israel.
Am J Rhinol Allergy. 2012 Jul-Aug;26(4):283-6. doi: 10.2500/ajra.2012.26.3776.
Pregnancy rhinitis manifests as nasal congestion, with resolution of symptoms after delivery. Eighteen to 30% of pregnant patients report symptoms of rhinitis. Pregnancy rhinitis may have an adverse effect on quality of life (QOL) and may cause obstructive sleep apnea (OSA), which in turn may adversely affect the outcome of pregnancy. Previous examinations of the prevalence of pregnancy rhinitis during different stages of pregnancy have been inconclusive. This study aimed to determine rhinosinusitis-specific QOL during different stages of pregnancy.
A cross-sectional observation study of patients in the second and third trimesters of pregnancy using the 22-item Sino-Nasal Outcome Test (SNOT-22) was conducted in the obstetric clinic at McGill University Health Center in Montreal, Canada. Seventy-six low- risk pregnant patients were included in the study. Thirty-two patients were in the second trimester of pregnancy and 44 patients were in the third trimester.
Average item scores for the entire questionnaire were significantly higher (p = 0.041), indicating more severe impairment of QOL, in the third trimester in comparison with the second trimester. A comparison between women with and without preexisting allergic rhinitis, in both the second and the third trimesters, shows significantly higher SNOT-22 scores for the allergic group (p = 0.007). QOL was lower in the third trimester than in nonrhinosinusitis patients (p = 0.011).
Rhinosinusitis-specific QOL is lower in the third trimester of pregnancy in comparison with the second trimester and also in comparison with nonrhinosinusitis patients. Increased awareness may enhance the QOL of pregnant patients, prevent OSA, and thereby positively influence the outcome of pregnancy.
妊娠性鼻炎表现为鼻塞,分娩后症状缓解。18%至 30%的妊娠患者报告有鼻炎症状。妊娠性鼻炎可能会降低生活质量(QOL),并可能导致阻塞性睡眠呼吸暂停(OSA),进而对妊娠结局产生不利影响。之前对不同孕期妊娠性鼻炎的患病率的检查结果并不一致。本研究旨在确定不同孕期的鼻炎特异性 QOL。
在加拿大麦吉尔大学健康中心的妇产科诊所,对妊娠中期和晚期的患者进行了一项横断面观察研究,使用了 22 项鼻-鼻窦炎结局测试(SNOT-22)。共纳入 76 例低风险妊娠患者。其中 32 例处于妊娠中期,44 例处于妊娠晚期。
整个问卷的平均项目评分在妊娠晚期明显更高(p = 0.041),表明与妊娠中期相比,QOL 受损更严重。与无过敏性鼻炎的女性相比,在妊娠中期和晚期,过敏性鼻炎组的 SNOT-22 评分明显更高(p = 0.007)。与非鼻炎患者相比,妊娠晚期的 QOL 较低(p = 0.011)。
与妊娠中期相比,妊娠晚期的鼻炎特异性 QOL 较低,与非鼻炎患者相比也是如此。提高认识可能会提高妊娠患者的 QOL,预防 OSA,并因此对妊娠结局产生积极影响。